Cerrato Biosciences is a Canadian startup developing adaptive inline sensors for bioprocess monitoring.
Our system combines light sensors with AI to generate real-time insights without manual sampling, complex calibration, or workflow disruption.
We focus on helping teams reduce batch risk, accelerate decisions, and stay compliant at scale.
Held early technical discussions with teams at BioVectra, CCRM, and OmniaBio. All confirmed the pain around lagging QC and expressed interest in adaptive inline sensing. The need is real and the opportunity is clear.
Integrated Cerrato’s pipeline into Master’s research at the University of Guelph. This forms the technical foundation for our white paper on real-time detection and AI-based profiling.
Started aligning data handling and audit trail features with 21 CFR Part 11 and ICH Q8 standards. Establishing internal structure to support future GMP pilot deployment.